Disclaimer: This site aggregates publicly available data from official government sources (FDA, ClinicalTrials.gov, PubMed, SEC EDGAR) for general reference only. It does NOT constitute medical advice, diagnosis, treatment recommendations, or investment advice.

FDA 510(k)

OPTX 20/20

K-Number: K953413 · 1995-08-07

ApplicantNeoptx, Inc.
Decision Date1995-08-07
Product CodeHQY
Advisory CommitteeOP
DecisionSubstantially Equivalent

Device Summary

OPTX 20/20 is the device name listed in this FDA 510(k) record. The listed applicant is Neoptx, Inc.. It received FDA 510(k) clearance on 1995-08-07 under 510(k) number K953413. The device is classified under product code HQY. It was reviewed by the OP advisory panel. FDA Decision: Substantially Equivalent.

Frequently Asked Questions

What is the OPTX 20/20?

OPTX 20/20 is a medical device that received FDA 510(k) clearance on 1995-08-07. The listed applicant is Neoptx, Inc.. The 510(k) number is K953413.

When did OPTX 20/20 receive FDA 510(k) clearance?

OPTX 20/20 received FDA 510(k) clearance on 1995-08-07, under 510(k) number K953413.

Who is the listed applicant for OPTX 20/20?

The FDA 510(k) record lists Neoptx, Inc. as the applicant. This does not by itself establish the device manufacturer.

What is the FDA product code for OPTX 20/20?

The FDA product code for OPTX 20/20 is HQY.

Related Devices (Code: HQY)

Related records are matched automatically using names, product codes, or other metadata. A match does not establish a verified clinical, scientific, corporate, or regulatory relationship; review the linked official sources.

Official Source

View on FDA Database →

Data sourced from FDA Open API. For the most current and authoritative information, always refer to the official record.

↑